Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123018 · ClinicalTrials.gov registry record
Screening for Memory Studies
A clinical trial of Dementia and Memory Loss, sponsored by John Wesson Ashford Jr.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01123018: Active study of Dementia and Memory Loss, sponsored by John Wesson Ashford Jr.
NCT01123018 is a study of Dementia and Memory Loss that is active but no longer recruiting, run by John Wesson Ashford Jr. The registered enrollment target is 2,000 participants, below the 7,713-participant average among 199 other Dementia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01123018, a study of Dementia and Memory Loss, is active but no longer recruiting, sponsored by John Wesson Ashford Jr.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We hope to recruit participants into various clinical trials and research projects.
Primary Outcome
The primary outcome measure on a 50 item Continuous Recognition Task with 25 repeated items, first display of an item is 3 seconds, new image immediately after a response (MemTrax, see: reference), is number of HITs (a memory measure). Less than 20 suggests memory impairment and will trigger referral to a memory study.
Conditions Studied
Interventions
- BEHAVIORAL Memtrax Memory screening test
Study Locations (1)
California
- VA Palo Alto Health Care System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2007-06 |
| Est. Completion | 2029-12 |
What the registry record for NCT01123018 still lists
NCT01123018 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 7,713-participant average among 199 other Dementia trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Memtrax Memory screening test is the first listed.
NCT01123018 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01123018 about?
NCT01123018 is a clinical study titled "Screening for Memory Studies". We hope to recruit participants into various clinical trials and research projects.
What is the current status of trial NCT01123018?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2007-06. Estimated completion is 2029-12.
What conditions does trial NCT01123018 study?
This clinical trial studies the following conditions: Dementia, Memory Loss, Memory Deficits.
What interventions are being tested in trial NCT01123018?
The interventions under investigation include: Memtrax Memory screening test (BEHAVIORAL).
Who is sponsoring clinical trial NCT01123018?
This trial is sponsored by John Wesson Ashford Jr, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01123018 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01123018's enrollment target sits among peer trials
2,000 23rd of 199 higher than 174 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia